Archives: Agenda

Explore how artificial intelligence is revolutionizing the speed, quality, and consistency within clinical trials through innovative technologies and real-world applications. This presentation explores:

• Preparing your organization
• How to identify AI opportunities and associated value
• Real life examples of using AI to accelerate clinical trials

• Discover how to achieve unparalleled accuracy and patient compliance through cutting-edge, low-touch technology
• Dive into the transformative power of AI and explore real-world applications reshaping cardiac care
• Understand how continuous monitoring ensures precise data collection and enhances patient adherence and safety
• Uncover the revolutionary role of AI in interpreting cardiac data
• Review practical examples and case studies demonstrating effectiveness of continuous cardiac monitoring in clinical settings

• Review the results of a public and patient survey on the use of AI to develop clinical trial documents
• Assess patient level of trust in and comfort with the use of AI to generate patient-facing clinical trial documents
• Discuss the patient’s views on the importance of human review of AI-generated content and implications for the future

• Planning for a successful sponsor/CRO relationship
• Defining goals, priorities and metrics
• Considerations when contemplating a CRO transition
• Overview of common challenges and pitfalls in CRO transitions
• Developing a detailed transition plan to minimize disruptions and ensure continuity

• Ensuring your trial is both cost-conscious and efficient without compromising on quality
• Techniques, processes and technology to improve forecasting and budgeting
• Avoiding common mistakes to keep your clinical trial budget on track

• Understand the key points of recent FDA guidance aimed at enhancing diversity and equity in clinical trials
• Discuss how recent FDA guidance supports patient optionality in clinical trials, especially for underrepresented populations
• Identify actionable strategies for integrating FDA guidance into clinical trial designs to achieve diversity and innovation goals
• Explore the potential impact of FDA guidance on future clinical trials, with an emphasis on patient-centricity and inclusivity

• Exposing the inefficiencies of current vendor qualification practices and challenging the industry to adopt a proven process innovation that will help sponsors onboard vendors more quickly leading to a real reduction in clinical trial start-up times
• Learn how embracing innovation, and adopting a risk-based data-driven approach to vendor management can help organizations strength their compliance practices in a heavily regulated industry
• Uncover the advantages of a centralized approach to vendor qualification that provides unique benefits to both sponsors and vendors across the globe

• Defining a start-up plan based on key study objectives
• Using a data driven approach for effective start-up planning, including data from regulatory intelligence, site intelligence, and KPIs to support start-up planning
• How effective start-up execution drives a successful trial